Dr Elizabeth Christie
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
71 Scholarly works
7 Projects
HIGHLIGHTS
2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
DOI: 10.1038/s41467-026-71134-32026
Journal article
Comparison of homologous recombination deficiency scoring methods in multi-site samples in high grade serous ovarian cancer
DOI: 10.1016/j.ijgc.2025.1042332025
Journal article
Biology of ovarian cancer: Models, microenvironment, and therapeutics: 15th Biennial Rivkin Center Ovarian Cancer Research Symposium
DOI: 10.1016/j.ygyno.2025.08.0142024
Research grants (international)
Improving Ovarian Cancer Outcomes by Understanding and Targeting Acquired Resistance
2019
Research Grant
Molecular and Spatial Characterization of Drug Resistance in Human Ovarian Cancer
2017
Research Grant
Understanding and Targeting Acquired Chemoresistance in High-Grade Serous Ovarian Cancer
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature14410
RECENT SCHOLARLY WORKS
2025
Journal article
Abstract B004: Evaluating spatial inter-tumor heterogeneity in whole genome duplication states and homologous recombination deficiency status in advanced ovarian high grade serous carcinoma
DOI: 10.1158/1538-7445.ovarian25-b0042025
Journal article
Genome doubling fuels ovarian cancer evolution and immune dysregulation
DOI: 10.1038/d41586-025-02059-y2025
Journal article
Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
DOI: 10.1038/s41587-024-02250-y2025
Journal article
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer
DOI: 10.1126/sciadv.ads74052025
Journal article
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer
DOI: 10.1038/s41420-025-02716-12024
Journal article
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
DOI: 10.1038/s41467-024-50137-y2024
Conference Proceedings
EV243/#1235 Genomic characteristics underlying homologous recombination deficient-negative scores in ovarian high grade serous cancer tumors
DOI: 10.1136/ijgc-2024-igcs.362
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Identifying the Key to Treatment Resistance in Ovarian Cancer